NTRK1 and myelodysplastic syndrome: For example, some genes, such as receptor tyrosine kinases (FLT3 and KIT) and RAS pathway genes, have a higher proportion of mutations in AML, whereas mutations in splicing factors (SF) and epigenetic regulators, among others, are more prevalent in MDS (20).